Scarica l'app Stockscreener
1.74
2.35%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.70
Aprire:
$1.7
Volume 24 ore:
48,109
Relative Volume:
0.34
Capitalizzazione di mercato:
$75.90M
Reddito:
-
Utile/perdita netta:
$-28.54M
Rapporto P/E:
-2.7188
EPS:
-0.64
Flusso di cassa netto:
$-22.72M
1 W Prestazione:
+0.00%
1M Prestazione:
+1.75%
6M Prestazione:
-6.45%
1 anno Prestazione:
-63.60%
Intervallo 1D:
$1.69
$1.74
Intervallo di 1 settimana:
$1.67
$1.75
Portata 52W:
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Nome
Essa Pharma Inc
Settore
Industria
Telefono
(778) 331-0962
Indirizzo
SUITE 720, VANCOUVER, BC
Confronta EPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.74 | 75.90M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-04 | Downgrade | Jefferies | Buy → Hold |
| 2024-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2021-03-04 | Iniziato | Piper Sandler | Overweight |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-02 | Iniziato | Jefferies | Buy |
| 2019-10-25 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Essa Pharma Inc Borsa (EPIX) Ultime notizie
14,525 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Bought by Squarepoint Ops LLC - Defense World
211,204 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Acquires Shares of 45,810 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
82,600 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Buys 812,302 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
BNP Paribas Financial Markets Raises Stock Holdings in ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationEPIX - ACCESS Newswire
Cubist Systematic Strategies LLC Buys Shares of 26,287 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination - TipRanks
ESSA Pharma: Fiscal Q2 Earnings Snapshot - CT Insider
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review - TipRanks
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 | EPIX Stock News - GuruFocus
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
ESSA Pharma Inc. (EPIX) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
A Look At Essa Pharma Inc (EPIX) Stock Performance - Stocksregister
Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long - openPR.com
Alis Biosciences Launches To Free Cash From Stalled-Out Biotechs - insights.citeline.com
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Investor pressures struggling Essa to liquidate, give cash to shareholders - Fierce Biotech
ESSA Pharma Inc. (NASDAQ:EPIX): Are Analysts Optimistic? - simplywall.st
EPIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your ESSA Pharma Inc. investment - ACCESS Newswire
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pha - GuruFocus
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider
EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus
ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.
ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal
Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Longview News-Journal
ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView
EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire
The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView
EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks
Essa Pharma Inc Azioni (EPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Essa Pharma Inc Azioni (EPIX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Virsik Peter | Chief Operating Officer |
Oct 07 '24 |
Sale |
6.03 |
694 |
4,185 |
7,776 |
| Virsik Peter | Chief Operating Officer |
Sep 09 '24 |
Sale |
6.00 |
694 |
4,164 |
8,470 |
| Virsik Peter | Chief Operating Officer |
Sep 03 '24 |
Sale |
6.03 |
2,082 |
12,554 |
9,164 |
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):